NFKB1 and Alzheimer disease: This observation is consistent with a previous report that S-GLSP improves cognitive function in a rat model of sporadic AD by inhibiting the NF-κB/NLRP3 inflammatory pathway in the medial prefrontal cortex (Qin et al., 2024).